Literature DB >> 22522336

Radiation-induced World Health Organization grade II meningiomas in young patients following prophylactic cranial irradiation for acute lymphoblastic leukemia in childhood. Three case reports.

Keiko Oda1, Taku Sato, Tadashi Watanabe, Masahiro Ichikawa, Eiji Ito, Yuka Matsumoto, Hitoshi Ando, Jun Sakuma, Atsushi Kikuta, Hiroshi Hojo, Kiyoshi Saito.   

Abstract

Current chemotherapeutic regimens have been used to successfully treat many children with acute lymphoblastic leukemia (ALL), but have resulted in an increased risk of late central nervous system tumors, most commonly meningioma, particularly in patients who have received cranial irradiation. We treated 3 young patients with World Health Organization grade II meningiomas who had previously received cranial irradiation for the treatment of childhood ALL: a cerebellopontine angle tumor in a 19-year-old woman, a petroclival tumor in a 28-year-old man, and a frontal parasagittal tumor in a 19-year-old woman. These cases were difficult to treat due to the aggressive and invasive biology of the tumors. Therefore, we recommend systematic cranial imaging and long follow-up periods for leukemia survivors to detect brain tumors before progression.

Entities:  

Mesh:

Year:  2012        PMID: 22522336     DOI: 10.2176/nmc.52.224

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  2 in total

1.  Secondary brain tumors after cranial radiation therapy: A single-institution study.

Authors:  Masazumi Fujii; Masahiro Ichikawa; Kensho Iwatate; Mudathir Bakhit; Masayuki Yamada; Yosuke Kuromi; Taku Sato; Jun Sakuma; Hisashi Sato; Atsushi Kikuta; Yoshiyuki Suzuki; Kiyoshi Saito
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-30

Review 2.  Cytogenetic findings in pediatric radiation-induced atypical meningioma after treatment of medulloblastoma: case report and review of the literature.

Authors:  María Sol Brassesco; Elvis Terci Valera; Luciano Neder; Julia Alejandra Pezuk; Ricardo Santos Oliveira; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  J Neurooncol       Date:  2012-10-18       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.